Bio-Techne Corp. closed 11.77% below its 52-week high of $75.69, which the company achieved on February 7th.

By Published If you or members of your book club can’t seem to get through long, heavy reads, we have some options for you: short biographies, essays, histories and other unique works of nonfiction ...

EXCLUSIVE: Luxbox has acquired international sales rights to Hungarian director Dénes Nagy ‘s upcoming film The Vacation ...

The White House posted an AI-altered picture of an ICE protester under arrest, made to look like she was sobbing remorsefully ...

CAMBRIDGE, Mass., Jan. 7, 2026 /PRNewswire/ -- STRM.BIO, a biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced $8 million in Series Seed ...

Over the last 30 years, there have been countless books about Tupac Shakur, of various quality. Much of the book focuses on penetrating the myths surrounding Pac. A significant portion discusses how, ...

Bianca Censori has taken control of her narrative in the form of doppelgängers. The architect, who is married to the artist formerly known as Kanye West, recently had her first publicized chat with ...

Accurate cell counting is critical in research, yet laboratories routinely face several challenges that can compromise results. Manual counting with haemocytometers is slow and subjective, often ...

Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women's health, today announced the close of a £5M pre-seed funding round, co-led by NfX and Eka VC, and including Cocoa VC, ...

Logos are more than just a pretty design—they tell a story about the company behind them. The Pivot Bio logo is a good example. It’s not just a name slapped on a product. There’s some real thinking ...

Bio-PE is derived from biological sources like sugarcane instead of petroleum. The manufacturing process begins with extracting ethanol from sugarcane, which is then dehydrated to produce ethylene, ...

Shares of Mustang Bio (NASDAQ:MBIO) jumped on Monday after the company said that the U.S. FDA has granted orphan drug status to its CAR T-cell therapy, MB-101, for the treatment of astrocytoma and ...